Eric Crombez - EVP and Chief Medical Officer at Ultragenyx Pharmaceutical Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
EVP and Chief Medical Officer
Issuer Symbol
RARE on Nasdaq
All Insider Reports
All Insider Reports

Eric Crombez - trading volume in the past year for Ultragenyx Pharmaceutical Inc.

Holdings reported by Eric Crombez for Ultragenyx Pharmaceutical Inc.

Security Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 76,301 $1,739,662 $22.80 02 Mar 2026 Direct
Stock Ooption (Right to Buy) 30,246 01 Mar 2025 Direct Common Stock

Transactions reported by Eric Crombez for Ultragenyx Pharmaceutical Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.